The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 732-735

  Buck, Todd B ^a,d   Yoshiji, H ^b   Harris, Steven R ^c   Bunce, Opal R ^d   Thorgeirsson, Unnur P ^a,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c Pikeville College   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; BREAST CANCER; BREAST CARCINOGENESIS; CONFERENCE PAPER; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032816215     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07775.x     Document Type: Conference Paper

References (5)

1. 1. Crawford, H.C. et al. 1994. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14: 234-245.
2. 2. Baker, T. et al. 1994. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br. J. Cancer. 70: 506-512.
3. 3. Naruo, S. et al. 1994. Serum levels of a tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients. Int. J. Urol. 1: 228-231.
4. 4. Oliver, G.W. et al. 1997. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244: 161-166.
5. 5. Aldaz, C.M. et al. 1996. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis 17(9): 2069-2072.